Is committed to building on success, and the continued in-licensing of products and technologies is an acknowledged strategic priority
Summary
AstraZeneca was formed on 6 April 1999 through the merger of Astra of Sweden and Zeneca Group of the UK. Astra was founded in 1913 and had been headquartered in Sodertalje, Sweden. Astra's research, development and marketing efforts were focused primarily on pharmaceutical products in four main product groups: gastrointestinal, cardiovascular, respiratory and pain control, as well as medical devices. Zeneca had been formed in June 1993, when Imperial Chemical Industries (ICI, founded in 1926) demerged three of its businesses (Pharmaceuticals, Agrochemicals and Specialties). Zeneca was a major international bioscience group engaged in the research, development, manufacture and marketing of pharmaceuticals (focusing on cancer, cardiovascular, central nervous system, respiratory and anaesthesia), agricultural chemicals and specialty chemicals, and the provision of disease-specific healthcare services. AstraZeneca is dedicated to the discovery, development, manufacturing and marketing of high quality, effective prescription medicines that bring benefit for patients and add value for shareholders and wider society.
All rights reserved. Terms and Conditions | Contact us
